Factor | Wagner2008 (10130)

Pulsed Tylosin Use

Swine | Grower-finisher

31

Description

Tylosin was fed at 100 g/ton in a pulsed fashion: 1wk+, 3wk-, 1wk+, 12wk-.

Resistance Outcomes

Resistance Microbe Outcome
Tetracycline
/
Salmonella spp. (Typing Performed)
See: Table 2 AMR+ (n) AMR- (n) Total (n)
Pulsed Tylosin Use 12 14
No Use 10 10
Tetracycline
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Pulsed Tylosin Use 96.70 150
No Use 94.80 128
Ceftiofur
/
Salmonella spp. (Typing Performed)
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Pulsed Tylosin Use 0.00 14
No Use 0.00 10
Ceftiofur
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Pulsed Tylosin Use 0.00 150
No Use 0.80 128
Amoxicillin And Beta-Lactamase Inhibitor
/
Salmonella spp. (Typing Performed)
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Pulsed Tylosin Use 0.00 14
No Use 0.00 10
Amoxicillin And Beta-Lactamase Inhibitor
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Pulsed Tylosin Use 2.00 150
No Use 0.00 128
Ampicillin
/
Salmonella spp. (Typing Performed)
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Pulsed Tylosin Use 50.00 14
No Use 10.00 10
Ampicillin
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Pulsed Tylosin Use 32.70 150
No Use 27.30 128
Cefalotin
/
Salmonella spp. (Typing Performed)
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Pulsed Tylosin Use 0.00 14
No Use 0.00 10
Cefalotin
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Pulsed Tylosin Use 10.70 150
No Use 3.90 128
Cefoxitin
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Pulsed Tylosin Use 2.00 150
No Use 0.00 128
Amikacin
/
Salmonella spp. (Typing Performed)
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Pulsed Tylosin Use 0.00 14
No Use 0.00 10
Cefoxitin
/
Salmonella spp. (Typing Performed)
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Pulsed Tylosin Use 0.00 14
No Use 0.00 10
Ciprofloxacin
/
Salmonella spp. (Typing Performed)
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Pulsed Tylosin Use 0.00 14
No Use 0.00 10
Gentamicin
/
Salmonella spp. (Typing Performed)
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Pulsed Tylosin Use 0.00 14
No Use 0.00 10
Nalidixic Acid
/
Salmonella spp. (Typing Performed)
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Pulsed Tylosin Use 0.00 14
No Use 0.00 10
Sulfamethoxazole And Trimethoprim
/
Salmonella spp. (Typing Performed)
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Pulsed Tylosin Use 0.00 14
No Use 0.00 10
Chloramphenicol
/
Salmonella spp. (Typing Performed)
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Pulsed Tylosin Use 35.70 14
No Use 0.00 10
Kanamycin
/
Salmonella spp. (Typing Performed)
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Pulsed Tylosin Use 0.00 14
No Use 10.00 10
Streptomycin
/
Salmonella spp. (Typing Performed)
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Pulsed Tylosin Use 85.70 14
No Use 100.00 10
Sulfamethoxazole
/
Salmonella spp. (Typing Performed)
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Pulsed Tylosin Use 85.70 14
No Use 90.00 10
Amikacin
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Pulsed Tylosin Use 0.00 150
No Use 0.00 128
Ceftriaxone
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Pulsed Tylosin Use 0.00 150
No Use 0.00 128
Ciprofloxacin
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Pulsed Tylosin Use 0.00 150
No Use 0.00 128
Nalidixic Acid
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Pulsed Tylosin Use 0.00 150
No Use 0.00 128
Chloramphenicol
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Pulsed Tylosin Use 12.00 150
No Use 10.20 128
Gentamicin
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Pulsed Tylosin Use 6.00 150
No Use 6.20 128
Kanamycin
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Pulsed Tylosin Use 35.30 150
No Use 20.30 128
Streptomycin
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Pulsed Tylosin Use 34.70 150
No Use 17.20 128
Sulfamethoxazole
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Pulsed Tylosin Use 40.00 150
No Use 18.80 128
Sulfamethoxazole And Trimethoprim
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Pulsed Tylosin Use 0.70 150
No Use 0.80 128